Inhibition of Tissue Factor Synthesis by Disruption of ERK Kinases and PKC Signaling Pathways in Human Vascular SMCs

J. M. Xuereb; P. Sié; B. Boneu; J. Constans

doi:10.1055/s-0037-1613980

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2000; 84(01): 129-136
DOI: 10.1055/s-0037-1613980

Commentary

Schattauer GmbH

Inhibition of Tissue Factor Synthesis by Disruption of ERK Kinases and PKC Signaling Pathways in Human Vascular SMCs

J. M. Xuereb

¹From Laboratoire de Recherche surl’Hémostase, Pavillon Ch. Lefebvre, Hôpital Purpan, Toulouse, France

,

P. Sié

¹From Laboratoire de Recherche surl’Hémostase, Pavillon Ch. Lefebvre, Hôpital Purpan, Toulouse, France

,

B. Boneu

¹From Laboratoire de Recherche surl’Hémostase, Pavillon Ch. Lefebvre, Hôpital Purpan, Toulouse, France

,

J. Constans

¹From Laboratoire de Recherche surl’Hémostase, Pavillon Ch. Lefebvre, Hôpital Purpan, Toulouse, France

› Author Affiliations

Abstract

Summary

Tissue Factor (TF), the receptor for plasma VII/VIIa and the initiator of blood coagulation, is inducible in vascular smooth muscle cells (SMCs) by growth factors and bacterial lysopolysaccharides (LPS) and is expressed in vivo after vascular injury. As TF expression is a determinant of the thrombogenicity of vascular lesions, we investigated the signal pathways involved in this process.

Human vascular SMCs were obtained from normal arteries and made quiescent by serum deprivation. Baseline TF antigen and activity were up-regulated by various agonists: fetal calf serum (FCS), LPS, and platelet derived growth factor (PDGF) being the most effectives but with different kinetics. TF expression induced by LPS was transient with a maximum 6 h after stimulation and returned to baseline levels after 24 h whereas TF expression induced by serum or PDGF was sustained for at least 24 h. Rapid and transient activation of Extracellular signal-Regulated Kinase (ERK) was observed after stimulation by PDGF and FCS, but not by LPS. The role of ERK, Ras and protein kinase C activities were investigated using specific inhibitors, PD 98059, manumycin A and calphostin C respectively. For TF induction by LPS, PKC activity was required and the ERK/Ras pathway was not involved. In contrast, the effect of PDGF was strictly ERK and Ras dependent, but partially prevented by PKC inhibitors. TF induction by FCS was ERK dependent but partially Ras and PKC dependent. In conclusion, TF expression appears to be a non-specific response of SMCs to numerous stimuli through multiple signal pathways which differ according to the inducing agent.

Keywords

Smooth muscle cells - tissue factor - extracellular signal regulated kinase - protein kinase C

Full Text

References

References
1 Sanders M. Molecular and cellular concepts in atherosclerosis. Pharmac Ther 1994; 61: 109.
2 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801.
3 Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human artherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996; 75: 451.
4 Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue Factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594.
5 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implication for disorders of haemostasis and thrombosis. Am J Pathol 1989; 134: 1087.
6 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839.
7 Marmur JD, Rossikhina M, Guha A, Fyte B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253.
8 Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca²⁺ mobilization and protein kinace C activation. J Clin Invest 1993; 91: 547.
9 Schecter AD, Giesen PLA, Taby O, Rosenfield CL, Rossikhina M, Fyte BS, Kohtz DS, Fallon JT, Nemerson Y, Taubman MB. Tissue factor expression in human arterial smooth muscle cells. TF is present in three pools after growth factor stimulation. J Clin Invest 1997; 100: 2276.
10 Xuereb JM, Sie P, Boneu B, Constans J. Up-Regulation of Tissue Factor expression by platelet derived growth factor in human vascular smooth muscle cells in culture. Role of mitogen-activated protein kinase and of intracellular cyclic AMP. Thromb Haemost 1997; 78: 1520.
11 Xuereb JM, Herbert JM, Sie P, Boneu B, Constans J. Effects of heparin and other sulfated polysaccharides on Tissue Factor expression induced by mitogenic and non mitogenic factors in human vascular smooth muscle cells. Thromb Haemost 1999; 81: 151.
12 Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1.
13 Cui MZ, Parry GCN, Edgington TS, Mackman N. Regulation of tissue factor gene expression in epithelial cells. Induction by serum and phorbol 12-myristate 13-acetate. Arterioscler Thromb 1994; 14: 807.
14 Pettersen KS, Wiiger MT, Narahara N, Andoh K, Gaudernack G, Prydz H. Induction of tissue factor synthesis in human umbilical vein endothelial cells involves protein kinase C. Thromb Haemost 1992; 67: 473.
15 Van Der Logt CPE, Dirven RJ, Reitsma PH, Bertina RM. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester. Blood Coagul Fibrinol 1994; 05: 211.
16 Ternisien C, Ollivier V, Khechai F, Ramani M, Hakim J, De Prost D. Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes. Thromb Haemost 1995; 73: 413.
17 Tremoli E, Prati L, Parolari A, Antona C, Colli S, Mussoni L. Serum and thrombin induce tissue factor expression in human smooth muscle cells. Thromb Haemost. 1995 73. 1080 (abstr).
18 Catalioto RM, Cucchi P, Renzetti AR, Criscuoli M, Subissi A. Human umbilical vein smooth muscle cells as a model to study thrombin generation and function: effect of thrombin inhibitors. Thromb Haemost 1996; 76: 603.
19 Lau LF, Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: Coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 1987; 84: 1182.
20 Hartzell S, Ryder K, Lanahan A, Lau LF, Nathans D. A growth factorresponsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol 1989; 09: 2567.
21 Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995; 92: 7686.
22 Hara M, Akasaka K, Akinaga S, Okabe M, Nakano H, Gomez R, Wood D, Uh M, Tamanoi F. Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci USA 1993; 90: 2281.
23 Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Comm 1989; 159: 548.
24 Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78: 747.
25 Malarkey K, Belham CM, Paul A, Graham A, McLees A, Scott PH, Plevin R. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J 1995; 309: 361.
26 Burgering BMT, Bos JL. Regulation of Ras-mediated signalling: more than one way to skin a cat. TIBS 1995; 20: 18.
27 Yang R-B, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284.
28 Steinmann S, Ulevitch RJ, Mackman N. Role of the lipopolysaccharide (LPS)-binding protein/CD14 pathways in LPS induction of tissue factor expression in monocytic cells. Arterioscler Thromb 1994; 14: 1202.
29 Meszaros K, Aberle S, Dedrick R, Machovich R, Horwitz A, Birr C, Theofan G, Parent JB. Monocyte tissue factor induction by lipopolysaccharide (LPS) : Dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein. Blood 1994; 83: 2516.
30 Yang GR-B, Mark MR, Gurney AL, Godowski PJ. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J Immunol 1999; 163: 639.
31 Weinstein SL, Sanghera JS, Lemke K, De Franco A, Pelech SL. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J Biol Chem 1992; 267: 14955.
32 Sanghera JS, Weinstein SL, Aluwalia M, Girn J, Pelech SL. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J Immunol 1996; 156: 4457.
33 Swantek JL, Cobb MH, Geppert TD. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol 1997; 17: 6274.
34 Ternisien C, Ramani M, Ollivier V, Khechai F, Vu T, Hakim J, De Prost D. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation. Thromb Haemost 1993; 70: 800.
35 Terry CM, Callahan KS. Protein kinase C regulates cytokine-induced tissue factor transcription and procoagulant activity in human endothelial cells. J Lab Clin Med 1996; 127: 81.
36 Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Böher H, Greten J, Martin E, Baeuerle PA, Waldherr R, Kisiel W, Ziegler R, Stern DM, Nawroth PP. Mechanism of the tumor necrosis factor α-mediated induction of endothelial tissue factor. J Biol Chem 1995; 270: 26419.
37 Oeth P, Parry GCN, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kB/Rel and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17: 365.
38 Jackson SP. Regulating transcription factor activity by phosphorylation. Trends in Cell Biology 1992; 02: 104.
39 Oeth P, Parry GCN, Kunsch C, Nantermet P, Rosen CA, Mackman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a κB-like site. Mol Cel Biol 1994; 14: 3772.
40 Ghosh S, Baltimore D. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 1990; 344: 678.
41 Zhou JN, Ljungdahl S, Shoshan MC, Swedenborg J, Linder S. Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway. Mol Carcinog 1998; 21: 234.
42 Cui MZ, Parry GCN, Oeth P, Larson H, Smith M, Huang RP, Adamson ED, Mackman N. Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem 1996; 271: 2731.
43 Tseng H, Peterson TE, Berk BC. Fluid shear stress stimulates mitogenactivated protein kinase in endothelial cells. Circ Res 1995; 75: 869.
44 Berk BC, Corson MA, Peterson TE, Tseng H. Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells – a hypothesis for calcium-dependent and calcium-independent events activated by flow. J Biomech 1995; 28: 1439.
45 Pearce MJ, McIntyre TM, Prescott SM, Zimmerman GA, Whatley RE. Shear stress activates cytosolic phospholipase A2 (cPLA2) and MAP kinase in human endothelial cells. Biochem Biophys Res Commun 1996; 218: 500.
46 Khachigian LM, Anderson KR, Halnon NJ, Gimbrone MA, Resnick N, Collins T. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. Arterioscler Thromb Vasc Biol 1997; 17: 2280.
47 Lin MC, Almus-Jacobs F, Chen HH, Parry GCN, Mackman N, Shyy JYJ, Chien S. Shear stress induction of the tissue factor gene. J Clin Invest 1997; 99: 737.
48 Houston P, Dickson MC, Ludbrook V, White B, Schwachtgen JL, McVey JH, Mackman N, Reese JM, Gorman DG, Campbell C, Braddock M. Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. Arterioscler Thromb Vasc Biol 1999; 19: 281.
49 Rottingen JA, Endens T, Camerer E, Iversen JG, Pryd Z. Binding of human factor VIIa to Tissue Factor induces cytosolic Ca⁺⁺ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize Tissue Factor. J Biol Chem 1995; 2470: 4650.
50 Bromberg ME, Konisberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92: 8205.
51 Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stera DM, Nawroth P. Tissue factor controls the balance of angiogenic and anti-angiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320.
52 Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmbach K, Danton MJS, Colbert MC, With DP, Fujikawa K, Davie EW, Degen JL. Fatal embryonic events in mice lacking tissue factor, the cell associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93: 6258.
53 Carmeliet P, Mackman N, Luther T, Gressens P, Van Vlaenderen I, Demunck Asper M, Breier G, Evrad P, Müller M, Risan W, Eddington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383: 73.
54 Toomey JR, Kratzer KE, Lasky NM, Broze GJ. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA 1997; 94: 6922.